Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1988 Jul;64(3):487–493.

Influence of tuftsin-like synthetic peptides derived from C-reactive protein (CRP) on platelet behaviour.

B A Fiedel 1
PMCID: PMC1385063  PMID: 3044982

Abstract

C-reactive protein (CRP) is an acute-phase reactant that modifies platelet function differently, depending upon its physiochemical state. Aggregated and ligand-complexed forms of CRP initiate the activation of platelets, whereas naturally occurring CRP peptides inhibit platelet activation. The present study documents neutral proteases of the polymorphonuclear leucocyte (PMN) to cleave CRP into reaction products with the potential to inhibit platelet activation, and explore the structure-function relationships involved in the regulation of platelet activation by CRP using synthetic CRP peptides. Evidence was obtained that (i) a minimum of two linear functional domains exist within CRP that influence platelet activation; (ii) they reside in the mid-portion and at the C-terminus of the CRP molecule; (iii) the mid-portion domain inhibits platelet activation stimulated by adenosine diphosphate (ADP) or acid-soluble collagen, whereas the C-terminal domain initiates platelet activation; (iv) the functional expression of the C-terminal domain is maximized when the linear peptide is immobilized on latex; and (v) both CRP domains contain a homologue of the immunoregulatory signal peptide, tuftsin. These data suggest that the molecular mechanisms by which platelet processes are modulated by CRP may be related to the presence of tuftsin homologues in CRP.

Full text

PDF
487

Images in this article

489Figure 1
on p.489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolton A. E., Hunter W. M. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J. 1973 Jul;133(3):529–539. doi: 10.1042/bj1330529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buchta R., Fridkin M., Pontet M., Romeo D. Synthetic peptides from C-reactive protein containing tuftsin-related sequences. Peptides. 1986 Nov-Dec;7(6):961–968. doi: 10.1016/0196-9781(86)90121-x. [DOI] [PubMed] [Google Scholar]
  3. Fiedel B. A., Ku C. S. Further studies on the modulation of blood coagulation by human serum amyloid P component and its acute phase homologue C-reactive protein. Thromb Haemost. 1986 Jun 30;55(3):406–409. [PubMed] [Google Scholar]
  4. Fiedel B. A., Simpson R. M., Gewurz H. Activation of platelets by modified C-reactive protein. Immunology. 1982 Mar;45(3):439–447. [PMC free article] [PubMed] [Google Scholar]
  5. Gewurz H., Mold C., Siegel J., Fiedel B. C-reactive protein and the acute phase response. Adv Intern Med. 1982;27:345–372. [PubMed] [Google Scholar]
  6. Gotschlich E. C., Edelman G. M. C-reactive protein: a molecule composed of subunits. Proc Natl Acad Sci U S A. 1965 Aug;54(2):558–566. doi: 10.1073/pnas.54.2.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Haverstick D. M., Cowan J. F., Yamada K. M., Santoro S. A. Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin. Blood. 1985 Oct;66(4):946–952. [PubMed] [Google Scholar]
  8. Lei K. J., Liu T., Zon G., Soravia E., Liu T. Y., Goldman N. D. Genomic DNA sequence for human C-reactive protein. J Biol Chem. 1985 Oct 25;260(24):13377–13383. [PubMed] [Google Scholar]
  9. Najjar V. A., Nishioka K. "Tuftsin": a natural phagocytosis stimulating peptide. Nature. 1970 Nov 14;228(5272):672–673. doi: 10.1038/228672a0. [DOI] [PubMed] [Google Scholar]
  10. Oliveira E. B., Gotschlich E. C., Liu T. Y. Primary structure of human C-reactive protein. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3148–3151. doi: 10.1073/pnas.74.8.3148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Osmand A. P., Friedenson B., Gewurz H., Painter R. H., Hofmann T., Shelton E. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci U S A. 1977 Feb;74(2):739–743. doi: 10.1073/pnas.74.2.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pepys M. B., Baltz M. L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212. doi: 10.1016/s0065-2776(08)60379-x. [DOI] [PubMed] [Google Scholar]
  13. Pierschbacher M., Hayman E. G., Ruoslahti E. Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1224–1227. doi: 10.1073/pnas.80.5.1224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Plow E. F., Marguerie G. Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3711–3715. doi: 10.1073/pnas.79.12.3711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Robey F. A., Ohura K., Futaki S., Fujii N., Yajima H., Goldman N., Jones K. D., Wahl S. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. J Biol Chem. 1987 May 25;262(15):7053–7057. [PubMed] [Google Scholar]
  16. Simpson R. M., Prancan A., Izzi J. M., Fiedel B. A. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein. Immunology. 1982 Sep;47(1):193–202. [PMC free article] [PubMed] [Google Scholar]
  17. Travis J., Bowen J., Baugh R. Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases. Biochemistry. 1978 Dec 26;17(26):5651–5656. doi: 10.1021/bi00619a011. [DOI] [PubMed] [Google Scholar]
  18. Vigo C. Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. J Biol Chem. 1985 Mar 25;260(6):3418–3422. [PubMed] [Google Scholar]
  19. Woo P., Korenberg J. R., Whitehead A. S. Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem. 1985 Oct 25;260(24):13384–13388. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES